Midaflur
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
JSmol) | |
| |
| |
Midaflur (
INN; EXP 338) is an extremely stable 3-imidazoline derivative with central skeletal muscle relaxant and sedative properties in humans[1] and other species of mammals, exhibiting consistently high oral bioavailability and a long duration of action. While its pharmacodynamics remain poorly understood, midaflur resembles meprobamate and pentobarbital in terms of observed effects while being considerably more potent.[2]